Mexico Home Diagnostic Testing Market Size, Share Analysis and Forecast Report (2025-2034)
Description
The Mexico home diagnostic testing market was valued at USD 284.03 Million in 2024 and is expected to grow at a CAGR of 5.00% , reaching USD 462.65 Million by 2034 . The market growth is driven by the rising prevalence of chronic diseases and growing health awareness among Mexico’s aging population. The market is also driven by the increasing demand for rapid and accurate home-based testing across the region.
Key Trends and Insights
The market is witnessing steady growth driven by increased awareness of personal health and the need for early disease detection. Chronic illnesses, such as diabetes, hypertension, and obesity, are highly prevalent, motivating consumers to adopt self-testing kits. Technological improvements, including rapid and accurate point-of-care tests, support market expansion. Telemedicine adoption and government health initiatives also promote remote monitoring. Both local and international manufacturers are introducing innovative and user-friendly products to cater to the rising demand among urban and semi-urban populations. The market is anticipated to grow at a CAGR of 5.00% during the forecast period of 2025-2034.
Mexico Home Diagnostic Testing Market Growth Drivers
Rising Adoption of At-Home HIV Diagnostic Testing in Mexico to Boost Market Growth
The launch of Abbott’s Panbio™ HIV Self-Test in Mexico in July 2024 is driving growth in the country’s market. Approved by COFEPRIS, this rapid, over-the-counter test allows individuals to detect HIV-1 and HIV-2 antibodies privately at home, delivering results within 15–20 minutes. Improving accessibility and reducing stigma associated with clinic-based testing encourages early diagnosis and timely treatment. This development reflects a broader trend toward self-administered diagnostics, boosting consumer confidence and expanding the home testing segment in Mexico.
Mexico Home Diagnostic Testing Market Trends
Major market trends include regulatory ease and rising consumer demand.
Ease in Regulatory Approvals to Impact the Market Size Positively
Effective from September 1, 2025, Mexico's health authority COFEPRIS introduced an Abbreviated Regulatory Pathway, enabling medical device and drug manufacturers to expedite approvals by leveraging prior authorizations from trusted international regulators. This streamlined process promises 30-day evaluations, aligning Mexico more closely with global regulatory standards and offering manufacturers a faster route to market. Such initiatives are expected to boost the market value for diagnostic tests in the forecast period.
Increasing Adoption of Home Diagnostic Testing to Boost Mexico Home Diagnostic Testing Market Demand
The market is experiencing a growing demand for home diagnostic testing solutions. Factors contributing to this trend include increased health awareness, the convenience of at-home testing, and advancements in diagnostic technologies. Consumers are seeking accessible and private options to monitor their health, leading to a rise in the adoption of home testing kits for various conditions. This shift is influencing market dynamics and encouraging innovation in the home diagnostic testing sector.
Mexico Home Diagnostic Testing Market Share
Urine Sample to Lead the Market by Sample
The urine sample segment emerged as the dominant category, capturing the largest revenue share of more than 30% during the historical period. This preference is largely driven by the convenience, non-invasiveness, and reliability of urine-based tests, which allow users to monitor a wide range of health conditions from the comfort of their homes. Additionally, the growing awareness of preventive healthcare and increasing adoption of at-home diagnostics among Mexican consumers have further fueled the demand for urine sample testing, reinforcing its leading position in the market.
Leading Players in the Mexico Home Diagnostic Testing Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Becton, Dickinson and Company
Headquartered in Franklin Lakes, New Jersey, BD was founded in 1897. The company specializes in medical technology, offering a range of diagnostic solutions, including instruments and reagents for infectious disease and cancer detection. In 2025, BD announced plans to merge its Biosciences & Diagnostic Solutions division with Waters Corporation in a USD 17.5 billion deal, aiming to enhance its focus on medical technology.
Abbott
Abbott Laboratories, established in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company. Its diagnostic portfolio includes point-of-care tests, glucose monitoring systems, and laboratory instruments. Abbott has been a pioneer in self-testing solutions, notably developing TestPack in 1986, a self-contained diagnostic test for blood-sophisticated immunoassay tests.
Quidel Corporation
Founded in 1979 and headquartered in San Diego, California, QuidelOrtho Corporation is a leading provider of diagnostic healthcare products. The company specializes in immunoassay and molecular testing, with a strong presence in point-of-care settings and clinical labs. In 2021, Quidel acquired Ortho Clinical Diagnostics, expanding its diagnostic capabilities.
F. Hoffmann La Roche
Roche, founded in 1896 and headquartered in Basel, Switzerland, is a global healthcare leader. Its diagnostics division offers a comprehensive range of tests, instruments, and digital solutions for disease prevention, diagnosis, and monitoring. Roche Diagnostics aims to transform healthcare by providing innovative diagnostic solutions worldwide.
Other players in the market include Nova Biomedical, ACON Laboratories, Inc., OraSure Technologies, Inc., BTNX, Inc., ARKRAY Inc. , andSiemens Healthcare GmbH .
Mexico Home Diagnostic Testing Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
Key Trends and Insights
- Based on sample, the urine sample segment held the largest revenue share (over 30%) during the historical period.
- By age group, the geriatric segment is expected to lead the market in the forecast period.
- By test type, the infectious disease testing segment accounted for 40% of the market in the historical period.
- Market Size (2024): USD 284.03 Million
- Projected Market Size (2034): USD 462.65 Million
- CAGR (2025-2034): 5.00%
The market is witnessing steady growth driven by increased awareness of personal health and the need for early disease detection. Chronic illnesses, such as diabetes, hypertension, and obesity, are highly prevalent, motivating consumers to adopt self-testing kits. Technological improvements, including rapid and accurate point-of-care tests, support market expansion. Telemedicine adoption and government health initiatives also promote remote monitoring. Both local and international manufacturers are introducing innovative and user-friendly products to cater to the rising demand among urban and semi-urban populations. The market is anticipated to grow at a CAGR of 5.00% during the forecast period of 2025-2034.
Mexico Home Diagnostic Testing Market Growth Drivers
Rising Adoption of At-Home HIV Diagnostic Testing in Mexico to Boost Market Growth
The launch of Abbott’s Panbio™ HIV Self-Test in Mexico in July 2024 is driving growth in the country’s market. Approved by COFEPRIS, this rapid, over-the-counter test allows individuals to detect HIV-1 and HIV-2 antibodies privately at home, delivering results within 15–20 minutes. Improving accessibility and reducing stigma associated with clinic-based testing encourages early diagnosis and timely treatment. This development reflects a broader trend toward self-administered diagnostics, boosting consumer confidence and expanding the home testing segment in Mexico.
Mexico Home Diagnostic Testing Market Trends
Major market trends include regulatory ease and rising consumer demand.
Ease in Regulatory Approvals to Impact the Market Size Positively
Effective from September 1, 2025, Mexico's health authority COFEPRIS introduced an Abbreviated Regulatory Pathway, enabling medical device and drug manufacturers to expedite approvals by leveraging prior authorizations from trusted international regulators. This streamlined process promises 30-day evaluations, aligning Mexico more closely with global regulatory standards and offering manufacturers a faster route to market. Such initiatives are expected to boost the market value for diagnostic tests in the forecast period.
Increasing Adoption of Home Diagnostic Testing to Boost Mexico Home Diagnostic Testing Market Demand
The market is experiencing a growing demand for home diagnostic testing solutions. Factors contributing to this trend include increased health awareness, the convenience of at-home testing, and advancements in diagnostic technologies. Consumers are seeking accessible and private options to monitor their health, leading to a rise in the adoption of home testing kits for various conditions. This shift is influencing market dynamics and encouraging innovation in the home diagnostic testing sector.
Mexico Home Diagnostic Testing Market Share
Urine Sample to Lead the Market by Sample
The urine sample segment emerged as the dominant category, capturing the largest revenue share of more than 30% during the historical period. This preference is largely driven by the convenience, non-invasiveness, and reliability of urine-based tests, which allow users to monitor a wide range of health conditions from the comfort of their homes. Additionally, the growing awareness of preventive healthcare and increasing adoption of at-home diagnostics among Mexican consumers have further fueled the demand for urine sample testing, reinforcing its leading position in the market.
Leading Players in the Mexico Home Diagnostic Testing Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Becton, Dickinson and Company
Headquartered in Franklin Lakes, New Jersey, BD was founded in 1897. The company specializes in medical technology, offering a range of diagnostic solutions, including instruments and reagents for infectious disease and cancer detection. In 2025, BD announced plans to merge its Biosciences & Diagnostic Solutions division with Waters Corporation in a USD 17.5 billion deal, aiming to enhance its focus on medical technology.
Abbott
Abbott Laboratories, established in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company. Its diagnostic portfolio includes point-of-care tests, glucose monitoring systems, and laboratory instruments. Abbott has been a pioneer in self-testing solutions, notably developing TestPack in 1986, a self-contained diagnostic test for blood-sophisticated immunoassay tests.
Quidel Corporation
Founded in 1979 and headquartered in San Diego, California, QuidelOrtho Corporation is a leading provider of diagnostic healthcare products. The company specializes in immunoassay and molecular testing, with a strong presence in point-of-care settings and clinical labs. In 2021, Quidel acquired Ortho Clinical Diagnostics, expanding its diagnostic capabilities.
F. Hoffmann La Roche
Roche, founded in 1896 and headquartered in Basel, Switzerland, is a global healthcare leader. Its diagnostics division offers a comprehensive range of tests, instruments, and digital solutions for disease prevention, diagnosis, and monitoring. Roche Diagnostics aims to transform healthcare by providing innovative diagnostic solutions worldwide.
Other players in the market include Nova Biomedical, ACON Laboratories, Inc., OraSure Technologies, Inc., BTNX, Inc., ARKRAY Inc. , andSiemens Healthcare GmbH .
Mexico Home Diagnostic Testing Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
- HIV Test Kits
- Diabetes and Glucose Tests
- Cholesterol and Triglycerides Tests
- Pregnancy Tests
- Infectious Disease Tests
- Urinary Tract Infection Tests
- Ovulation Predictor Test Kits
- Others
- Strips
- Cassette
- Test Panel
- Midstream
- Dip Card
- Others
- Urine
- Saliva
- Blood
- Others
- Pediatrics
- Adults
- Geriatrics
- Retail Pharmacies/Drug Stores
- Hospital Pharmacies
- Online Pharmacies
- What was the Mexico home diagnostic testing market value in 2024?
- What is the Mexico home diagnostic testing market forecast outlook for 2025-2034?
- What is the market breakup based on type?
- What is the market breakup based on product?
- What is the market breakup based on application?
- What is the market breakup based on the end user?
- What are the major factors aiding the Mexico home diagnostic testing market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Mexico home diagnostic testing market trends?
- Which type will lead the market segment?
- Which product will lead the market segment?
- Which application will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the Mexico home diagnostic testing market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Home Diagnostic Testing Market Overview
- 3.1 Latin America Home Diagnostic Testing Market Overview
- 3.1.1 Latin America Home Diagnostic Testing Market Historical Value (2018-2024)
- 3.1.2 Latin America Home Diagnostic Testing Market Forecast Value (2025-2034)
- 3.2 Mexico Home Diagnostic Testing Market Overview
- 3.2.1 Mexico Home Diagnostic Testing Market Historical Value (2018-2024)
- 3.2.2 Mexico Home Diagnostic Testing Market Forecast Value (2025-2034)
- 4 Mexico Home Diagnostic Testing Market Landscape
- 4.1 Mexico Home Diagnostic Testing Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Mexico Home Diagnostic Testing Market: Product Landscape
- 4.2.1 Analysis by Test Type
- 4.2.2 Analysis by Product
- 4.2.3 Analysis by Sample
- 5 Mexico Home Diagnostic Testing Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 PESTEL Analysis
- 5.3.1 Political
- 5.3.2 Economic
- 5.3.3 Social
- 5.3.4 Technological
- 5.3.5 Legal
- 5.3.6 Environment
- 5.4 Porter’s Five Forces Model
- 5.4.1 Bargaining Power of Suppliers
- 5.4.2 Bargaining Power of Buyers
- 5.4.3 Threat of New Entrants
- 5.4.4 Threat of Substitutes
- 5.4.5 Degree of Rivalry
- 5.5 Key Demand Indicators
- 5.6 Key Price Indicators
- 5.7 Industry Events, Initiatives, and Trends
- 5.8 Value Chain Analysis
- 6 Mexico Home Diagnostic Testing Market Segmentation (218-2034)
- 6.1 Mexico Home Diagnostic Testing Market (2018-2034) by Test Type
- 6.1.1 HIV Test Kits
- 6.1.2 Diabetes and Glucose Test
- 6.1.3 Cholesterol and Triglycerides Tests
- 6.1.4 Pregnancy Tests
- 6.1.5 Infectious Disease Tests
- 6.1.6 Urinary Tract Infection Tests
- 6.1.7 Ovulation Predictor Test Kits
- 6.1.8 Others
- 6.2 Mexico Home Diagnostic Testing Market (2018-2034) by Product
- 6.2.1 Strips
- 6.2.2 Cassette
- 6.2.3 Test Panel
- 6.2.4 Midstream
- 6.2.5 Dip Card
- 6.2.6 Others
- 6.3 Mexico Home Diagnostic Testing Market (2018-2034) by Sample
- 6.3.1 Urine
- 6.3.2 Saliva
- 6.3.3 Blood
- 6.3.4 Others
- 6.4 Mexico Home Diagnostic Testing Market (2018-2034) by Age Group
- 6.4.1 Pediatrics
- 6.4.2 Adults
- 6.4.3 Geriatrics
- 6.5 Mexico Home Diagnostic Testing Market (2018-2034) by Distribution Channel
- 6.5.1 Retail Pharmacies/Drug Stores
- 6.5.2 Hospital Pharmacies
- 6.5.3 Online Pharmacies
- 7 Regulatory Framework
- 8 Funding and Investment Analysis
- 8.1 Analysis by Funding Instances
- 8.2 Analysis by Type of Funding
- 8.3 Analysis by Funding Amount
- 8.4 Analysis by Leading Players
- 8.5 Analysis by Leading Investors
- 8.6 Analysis by Geography
- 9 Strategic Initiatives
- 9.1 Analysis by Partnership Instances
- 9.2 Analysis by Type of Initiatives
- 9.3 Analysis by Leading Players
- 9.4 Analysis by Geography
- 10 Supplier Landscape
- 10.1 Vendor Positioning Analysis
- 10.1.1 Key Vendors
- 10.1.2 Prospective Leaders
- 10.1.3 Niche Leaders
- 10.1.4 Disruptors
- 10.2 Market Share Analysis, By Country (Top 5 Companies)
- 10.3 Becton, Dickinson and Company
- 10.3.1 Financial Analysis
- 10.3.2 Product Portfolio
- 10.3.3 Demographic Reach and Achievements
- 10.3.4 Company News and Developments
- 10.3.5 Certifications
- 10.4 Abbott
- 10.4.1 Financial Analysis
- 10.4.2 Product Portfolio
- 10.4.3 Demographic Reach and Achievements
- 10.4.4 Company News and Developments
- 10.4.5 Certifications
- 10.5 Quidel Corporation
- 10.5.1 Financial Analysis
- 10.5.2 Product Portfolio
- 10.5.3 Demographic Reach and Achievements
- 10.5.4 Company News and Developments
- 10.5.5 Certifications
- 10.6 F. Hoffmann La Roche
- 10.6.1 Financial Analysis
- 10.6.2 Product Portfolio
- 10.6.3 Demographic Reach and Achievements
- 10.6.4 Company News and Developments
- 10.6.5 Certifications
- 10.7 Nova Biomedical
- 10.7.1 Financial Analysis
- 10.7.2 Product Portfolio
- 10.7.3 Demographic Reach and Achievements
- 10.7.4 Company News and Developments
- 10.7.5 Certifications
- 10.8 Siemens Healthcare GmbH
- 10.8.1 Financial Analysis
- 10.8.2 Product Portfolio
- 10.8.3 Demographic Reach and Achievements
- 10.8.4 Company News and Developments
- 10.8.5 Certifications
- 10.9 ACON Laboratories, Inc.
- 10.9.1 Financial Analysis
- 10.9.2 Product Portfolio
- 10.9.3 Demographic Reach and Achievements
- 10.9.4 Company News and Developments
- 10.9.5 Certifications
- 10.10 OraSure Technologies, Inc.
- 10.10.1 Financial Analysis
- 10.10.2 Product Portfolio
- 10.10.3 Demographic Reach and Achievements
- 10.10.4 Company News and Developments
- 10.10.5 Certifications
- 10.11 BTNX, Inc.
- 10.11.1 Financial Analysis
- 10.11.2 Product Portfolio
- 10.11.3 Demographic Reach and Achievements
- 10.11.4 Company News and Developments
- 10.11.5 Certifications
- 10.12 ARKRAY Inc.
- 10.12.1 Financial Analysis
- 10.12.2 Product Portfolio
- 10.12.3 Demographic Reach and Achievements
- 10.12.4 Company News and Developments
- 10.12.5 Certifications
- 11 Mexico Home Diagnostic Testing Market – Distribution Model (Additional Insight)
- 11.1 Overview
- 11.2 Potential Distributors
- 11.3 Key Parameters for Distribution Partner Assessment
- 12 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
